Related Experiment Video
Updated: Mar 20, 2026

Laboratory Administration of Transcutaneous Auricular Vagus Nerve Stimulation taVNS: Technique, Targeting, and Considerations
Published on: January 7, 2019
Treatment of post-COVID symptoms with auricular vagus nerve stimulation
Patrick Gebetsroither1, Thomas Ettenauer2, Rudolf Likar2
1Private Practice, Quellenweg 2, 4501, Neuhofen, Austria. ordination@neuro-neuhofen.at.
Abstract:
We present a retrospective analysis of nine long COVID patients undergoing auricular vagus nerve stimulation for 4 weeks. Questionnaires screening for 35 symptoms and 22 aspects of quality of life showed improvements in 28/35 symptoms immediately after treatment, of which 19 persisted at the 12-week follow-up. Most benefits were reported with regards to pain, fatigue, post-exertional malaise, sleep and dysautonomia. Furthermore, the vast majority (19 out of 22) of aspects of quality of life were reported to have improved to various degrees.

